XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (16,198) $ (18,994)
Adjustments to reconcile net loss to net cash used in operations:    
Share-based compensation 6,519 9,467
Depreciation and amortization 941 1,816
Amortization of right-of-use assets 613 643
Impairment of right-of-use assets 0 186
Allowance for doubtful accounts 170 109
Change in fair value of warrant liabilities (191) (4,447)
Other 4 (10)
Changes in operating assets and liabilities:    
Accounts receivable (1,317) (1,596)
Prepaid expenses and other assets 506 1,125
Accounts payable 461 1,066
Accrued expenses and other liabilities 396 2,782
Accrued compensation and benefits (3,833) (3,967)
Operating lease liabilities (904) (555)
Net cash used in operating activities (12,833) (12,375)
Cash flows from investing activities:    
Purchases of investments and term deposits (22,012) 0
Maturities of term deposits 534 0
Purchases of property and equipment (51) (400)
Net cash used in investing activities (21,529) (400)
Cash flows from financing activities:    
Proceeds from exercise of options 26 226
Taxes withheld and paid related to net share settlement of equity awards (679) (2,302)
Net cash used in financing activities (653) (2,076)
Effect of changes in currency exchange rates on cash and cash equivalents 358 (253)
Net decrease in cash and cash equivalents (34,657) (15,104)
Cash, cash equivalents and restricted cash, beginning of the period 106,256 145,785
Cash, cash equivalents and restricted cash, end of the period 71,599 130,681
Reconciliation of cash, cash equivalents and restricted cash to the amounts reported within the consolidated balance sheets    
Cash and cash equivalents 70,472 129,606
Restricted cash 1,127 1,075
Total cash, cash equivalents and restricted cash, end of the period 71,599 130,681
Supplemental disclosure of non-cash investing and financing activities:    
Lease liabilities arising from obtaining right-of-use assets 0 4,506
Vesting of early exercised stock options and restricted stock awards 18 36
Purchase of property and equipment accrued and not yet paid $ 0 $ 25